Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Imagion Biosystems Limited

INVESTOR PRESENTATION - Imagion Biosystems Limited

ASX:IBX

Imagion Biosystems Limited

Health

Imagion Biosystems Limited (IBX) was incorporated on 6th December 2016. The Company's underlying business was founded in the United States. Shortly after its incorporation Imagion Biosystems Limited purchased all of the issued share capital in Imagion US from Manhattan Scientifics. The company's proprietary technologies and methods employ magnetic nanoparticles targeted towards cells associated with cancer and other diseases and provide the ability to detect these cells using highly sensitive magnetic sensors.

Read more

Market Cap

$179.71m

Price at Close

$0.18

4w avg. Volume

7.14m

4w avg. Turnover

$1.14m

Announcements
announcementt+2 movementdate
  • Appendix 2A - Fully Paid Ordinary Shares

    Issued Capital

  • -

    18 Jan 2021

-

18 Jan 2021
  • Cleansing Notice under Section 708A

    Issued Capital

  • -

    18 Jan 2021

-

18 Jan 2021
  • Cleansing Notice under Section 708A

    Issued Capital

  • +8.00%

    21 Dec 2020

+8.00%

21 Dec 2020
  • Appendix 2A - Fully Paid Ordinary Shares

    Issued Capital

  • +8.00%

    21 Dec 2020

+8.00%

21 Dec 2020
  • Imagion Biosystems December 2020 Investor Newsletter

    Letter To Shareholders

  • 0.00%

    16 Dec 2020

0.00%

16 Dec 2020
  • First-in-human study update - Study open for enrolment

    Progress Report

  • -13.33%

    15 Dec 2020

-13.33%

15 Dec 2020
  • Issue of Rights & Options under EIP

    Issued Capital

  • -13.33%

    15 Dec 2020

-13.33%

15 Dec 2020
  • Appendix 3G

    Issued Capital

  • -13.33%

    15 Dec 2020

-13.33%

15 Dec 2020
  • Resignation and Appointment of Company Secretary

    Company Administration

  • -10.71%

    07 Dec 2020

-10.71%

07 Dec 2020
  • Cleansing Notice under Section 708A

    Issued Capital

  • +13.04%

    27 Nov 2020

+13.04%

27 Nov 2020
Market Data

Current Price

$0.18

52WK HIGH

$0.2

52WK LOW

$0.01

1YR RETURN

+429.41%

1YR RETURN VS. SECTOR

+392.59%

90 DAY RETURN

+130.77%

ASX RANK

650

/2,047

SECTOR RANK

55

/168

SHARES OUTSTANDING

998.37m
ASX:IBX

Imagion Biosystems Limited

Health

Imagion Biosystems Limited (IBX) was incorporated on 6th December 2016. The Company's underlying business was founded in the United States. Shortly after its incorporation Imagion Biosystems Limited purchased all of the issued share capital in Imagion US from Manhattan Scientifics. The company's proprietary technologies and methods employ magnetic nanoparticles targeted towards cells associated with cancer and other diseases and provide the ability to detect these cells using highly sensitive magnetic sensors.

Read more

Market Cap

$179.71m

Price at Close

$0.18

4w avg. Volume

7.14m

4w avg. Turnover

$1.14m

ASX:IBX is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.